Metabolic Profiling of Rat Brain and Cognitive Behavioral Tasks: Potential Complementary Strategies in Preclinical Cognition Enhancement Research
Authors:
- 10 November 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 8 (12) , 5679-5690
Abstract
In this study, the correlation between the metabolic profiles of rats undergoing cognition enhancement drug therapy and their associated cognitive behavioral outcomes were investigated. Male Lister Hooded rats were administered either with donepezil, galantamine, or vehicle and subjected to Atlantis watermaze training and novel object recognition tests. An UPLC/MS/MS method was developed to profile 21 neurologically related metabolites in the rat brains. Pharmacologically induced behavioral changes were compared subsequently with the metabolic fluctuations of neurologically related metabolites from multiple neurotransmitter pathways using multivariate and univariate statistical analyses. Significant improvements in cognitive behavioral outcomes were demonstrated in the rats administered with donepezil and galantamine using both AWM training (P < 0.05) and NOR (P < 0.05) tests as compared to those dosed with the vehicle. This corroborated with the significant elevation of eight prominent biomarkers after the cognitive enhancement therapy. An orthogonal partial least-squares discriminant analysis model generated using only the 8 metabolites identified as discriminating the drug-dosed rats from the vehicle-dosed rats gave a Q(2) = 0.566, receiver operator characteristic (ROC) AUC = 1.000, using 7-fold cross validation. Our study suggests that metabolic profiling of rat brain is a potential complementary strategy to the cognitive behavioral tasks for characterizing neurobiological responses to cognition enhancement drug testing.Keywords
This publication has 57 references indexed in Scilit:
- G-CSF rescues the memory impairment of animal models of Alzheimer's diseaseJournal of Experimental Medicine, 2007
- Preclinical research into cognition enhancersTrends in Pharmacological Sciences, 2006
- Immunology and immunotherapy of Alzheimer's diseaseNature Reviews Immunology, 2006
- Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal modelsJournal of Alzheimer’s Disease, 2004
- Animal cognition: defining the issuesNeuroscience & Biobehavioral Reviews, 2004
- Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasksBrain Research Reviews, 2003
- Role of the Immune System in the Pathogenesis, Prevention and Treatment of Alzheimer??s DiseaseDrugs & Aging, 2003
- Preclinical experiments on cognition enhancement in Alzheimer's disease: Drugs affecting nicotinic acetylcholine receptorsDrug Development Research, 2002
- Overview and perspective on the therapy of alzheimer's disease from a preclinical viewpointProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2001
- Taking stock of cognition enhancersTrends in Pharmacological Sciences, 1991